[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569185":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":30,"responsibleParty":47,"collaborators":50,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":10,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":65,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":73,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Tianjin Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Diagnostic Test: Single Group Assignment",null,"Each subject receive a single intravenous injection of 68Ga\u002F18F-TATE\u002FJR11\u002FLM3 , and undergo PET\u002FCT imaging within the specificed time.",[13],"Diagnostic Test: 68Ga\u002F18F-TATE\u002FJR11\u002FLM3",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","68Ga\u002F18F-TATE\u002FJR11\u002FLM3","Each subject receive a single intravenous injection of 68Ga\u002F18F-TATE\u002FJR11\u002FLM3, and undergo PET\u002FCT imaging within the specificed time.",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Haonan Yu, MD","CONTACT","+8613821000597","dreamadam@126.com",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},"Shaobo Yao, PhD","+8615122570279","yaoshaobo008@163.com",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Tianjin Medical University General Hospital","RECRUITING","Tianjin","Tianjin Municipality","300052","China","CN",{"type":40,"coordinates":41},"Point",[42,43],117.17667,39.14222,{"lat":43,"lon":42},[46],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},{"type":48,"investigatorFullName":27,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Prof.",[51],{"name":32,"class":6},"100569185","somatostatin-receptor-petct-in-sstr-related-disease-patients-100569185",false,"NCT06690957","Somatostatin Receptor PET\u002FCT in SSTR-Related Disease Patients","Inclusion Criteria:\n\n\\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled SSTR PET\u002FCT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.\n\nExclusion Criteria:\n\n\\- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.",true,"ALL","18 Years","80 Years",{"count":63,"type":64},500,"ESTIMATED","7 Days","OBSERVATIONAL","To evaluate the potential usefulness of 68Ga\u002F18F-TATE\u002FJR11\u002FLM3 positron emission tomography\u002Fcomputed tomography (PET\u002FCT) for the diagnosis of primary and metastatic lesions in various SSTR-related disease patients.",[69,70,71,72],"SSTR-related Disease","Tumor","Positron Emission Tomography","Metastasis",[74,75,76,77],"PET\u002FCT","SSTR","Angonist","Antagonist","2025-02-07",{"date":80,"type":81},"2025-02-11","ACTUAL",{"date":83,"type":81},"2019-02-01",{"date":85,"type":64},"2027-10-01",{"name":5,"class":6},1]